Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.
AUTOR(ES)
Strandberg, D A
RESUMO
The susceptibilities of 159 clinical isolates of glucose nonfermentative gram-negative bacilli were determined for eight new monobactam or beta-lactam antibiotics. Imipemide (N-formimidoyl thienamycin) was effective against the largest number of species, although not against Pseudomonas maltophilia. Cefoperazone and ceftazidime, but not cefsulodin, were active against infrequently isolated Pseudomonas species. Aztreonam, moxalactam, cefotaxime, and ceftizoxime demonstrated selective activity against several species, including certain amino-glycoside-resistant isolates.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185153Documentos Relacionados
- Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli.
- Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli.
- In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
- Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli.
- Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.